News | January 23, 2012

Virginia Physicians Use Elekta Software to Better Target Moving Liver Tumors

January 23, 2012 — In treatments of the first handful of patients with lung or liver tumors, Riverside and University of Virginia Radiosurgery Center in Newport News, Va., clinicians have demonstrated the benefit that Elekta's Symmetry 4-D image guidance technology provides for patients whose tumors move with their breathing. Symmetry essentially yields a more distinct picture of the tumor, without the blurring associated with breathing motion.

By having a clearer picture of the tumor position and its motion, physicians have been able to improve the targeting of tumors, thereby avoiding having to treat a larger margin of healthy tissue around the lesion. A Symmetry scan is acquired just before treatment to ensure that the patient is correctly positioned, and to visualize tumor movement.

"Symmetry scans give us clearer information about the movement of the tumor, allowing us to increase the safety of treating our patients by decreasing the dose to healthy tissues, while hopefully providing a better clinical outcome," according to Riverside medical physicist Kelly Spencer.

Tumor Motion in Sharper Focus

Before they began using the Symmetry feature in Elekta's XVI package of image-guided radiation therapy (IGRT) tools, Riverside clinicians were using sophisticated XVI 3-D cone beam computed tomography (CBCT) VolumeView CBCT imaging technology integrated with their Elekta Synergy S to image tumors. These pre-treatment scans provide physicians with added confidence in the margins that they have planned. Although seeing a target with IGRT technology such as VolumeView has been a key clinical improvement, the motion still created a blur that encompassed the tumor's range of motion.

"For our current protocol, we would create an ITV [internal target volume] to cover the blur we see on the VolumeView," Spencer said. "We began using Symmetry on a couple of patients with lower lung lesions near the diaphragm where we would expect tumor motion to be an issue. We were actually quite mesmerized by the images Symmetry provided. We could clearly see the actual motion of the delineated tumor with respect to the patient's breathing."

The same Symmetry benefit applied to a recent patient with a liver tumor situated near the diaphragm. In this case, clinicians inferred tumor motion by observing the movement of the liver with the patient's breathing.

"We wanted to use Symmetry to see how the superior border of the liver moved, and what we observed was that it did not move simply superior to inferior – there was almost a rolling pattern to the liver motion," Spencer said. "We knew that the liver didn't necessarily move symmetrically on CBCT scans, but it was harder to appreciate due to motion artifact. This movement probably varies between patients, so that is an excellent reason to use Symmetry to evaluate this motion on a case-by-case basis."

The extent of tumor motion as depicted in a Symmetry scan helps clinicians confirm that the margins around the tumor that they applied during the planning phase are as small as possible, thereby protecting healthy uninvolved tissues.

"For example, The Radiation Therapy Oncology Group SBRT Lung protocol criterion is 1 cm margins superior and inferior on the gross tumor volume," he noted. "With Symmetr,y we can potentially reduce the standard margins and thereby decrease the dose to the uninvolved lung tissues."

Accounting for tumor motion is especially important for patients with lung tumors, as Riverside's protocol calls for beam delivery while the patient is breathing freely.

"Many of our lung cancer patients are older; they often have chronic obstructive pulmonary disease or emphysema, so their shortness of breath and erratic breathing pattern makes them unsuited for breath hold treatments or any sort of gating," Spencer said.

He added that eight out of 10 patients with lung tumors could benefit from a Symmetry scan.

"We are very excited about our future with Symmetry," he said. "We expected to be able to see a clearer picture of tumor motion, but we hadn't appreciated how well we would see the motion in all three dimensions. It hasn't been just superior to inferior tumor motion; Symmetry shows how a tumor can move anterior to posterior or left to right. In that respect, Symmetry has really exceeded our initial expectations."

For more information: www.elekta.com

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Overlay Init